BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3233881)

  • 1. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behçet's disease and class II and III antigens of the major histocompatibility complex].
    Hamza M; Ayed K; Bardi R; Gorgi Y; Meddeb N
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):59-61. PubMed ID: 2320926
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic study of Behçet's disease in Taiwan Chinese.
    Chung YM; Tsai ST; Liao F; Liu JH
    Tissue Antigens; 1987 Aug; 30(2):68-72. PubMed ID: 3672493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombination sites in the HLA class II region are haplotype dependent.
    Gregersen PK; Kao H; Nunez-Roldan A; Hurley CK; Karr RW; Silver J
    J Immunol; 1988 Aug; 141(4):1365-8. PubMed ID: 3135331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in uveitis.
    Cuccia Belvedere M; Martinetti M; de Paoli F; Mazzacane D; Redaelli C; Tafi A; Morone G
    Dis Markers; 1986 Oct; 4(3):243-6. PubMed ID: 3452481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
    Nakayama T
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some specific human leukocyte antigen (HLA)-DR/DQ haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease.
    Sun A; Hsieh RP; Chu CT; Wang JT; Liu BY; Chiang CP
    J Oral Pathol Med; 2001 Aug; 30(7):402-7. PubMed ID: 11488417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and celiac disease in Argentina: involvement of the DQ subregion.
    Palavecino EA; Mota AH; Awad J; Derosa S; Herrera M; Chertkoff L; Satz L; Fainboim L
    Dis Markers; 1990; 8(1):5-10. PubMed ID: 2311351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group.
    Moore SB; O'Duffy JD
    J Rheumatol; 1986 Aug; 13(4):771-3. PubMed ID: 3772926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
    Lehner T; Welsh KI; Batchelor JR
    Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
    Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel.
    Awad J; Navarrete C; Festenstein H
    Tissue Antigens; 1987 Jan; 29(1):55-9. PubMed ID: 3473746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-D region restriction fragment associated with refractory Behçet's disease.
    Numaga J; Matsuki K; Mochizuki M; Minami M; Juji T
    Am J Ophthalmol; 1988 May; 105(5):528-33. PubMed ID: 2897165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
    Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
    Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR and DQ antigens in Chinese patients with Behçet's disease.
    Sun A; Lin SC; Chu CT; Chiang CP
    J Oral Pathol Med; 1993 Feb; 22(2):60-3. PubMed ID: 8445544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens in Behçet's disease with refractory ocular attacks.
    Matsuki K; Juji T; Tokunaga K; Mochizuki M; Hayashi K; Fujino Y; Numaga J; Yamashita H
    Tissue Antigens; 1987 Apr; 29(4):208-13. PubMed ID: 3617033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
    Ohno S
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
    Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
    Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.